AI Article Synopsis

  • - The systematic review aims to evaluate the effects of postoperative therapy on patients with resected squamous cell carcinoma of the head and neck (SCCHN) and to identify the best evidence-based recommendations for common clinical situations.
  • - Medical literature was analyzed following PRISMA guidelines, with 5660 studies initially identified, leading to a review of 101 relevant studies from 1977 to 2020, covering both oncologic and quality of life outcomes.
  • - The findings supported consensus statements about optimal postoperative therapy; however, further research is needed in areas where the expert panel could not reach agreement on specific treatments.

Article Abstract

Background: The aims of this systematic review are to (a) evaluate the current literature on the impact of postoperative therapy for resected squamous cell carcinoma of the head and neck (SCCHN) on oncologic and non-oncologic outcomes and (b) identify the optimal evidence-based postoperative therapy recommendations for commonly encountered clinical scenarios.

Methods: An analysis of the medical literature from peer-reviewed journals was conducted using the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guideline. Prospective studies and methodology-based systematic reviews and meta-analyses of postoperative therapy for SCCHN were identified by searching Medline (OVID) and EMBASE (Elsevier) using controlled vocabulary terms (ie, National Library of Medicine Medical Subject Headings [MeSH], EMTREE). Study screening and selection was performed with Covidence software and full-text review. The RAND/UCLA appropriateness method was used by the expert panel to rate the appropriate use of postoperative therapy, and the modified Delphi method was used to come to consensus.

Results: A total of 5660 studies were identified and screened using the title and abstract, leading to 201 studies assessed for relevance using full-text review. After limitation to the eligibility criteria, 101 studies from 1977 to 2020 were identified, including 77 with oncologic endpoints and 24 with function and quality of life endpoints. All studies reported staging prior to the implementation of American Joint Committee on Cancer (AJCC-8).

Conclusions: Prospective clinical studies and systematic reviews identified through the PRISMA systematic review provided good evidence for consensus statements regarding the appropriate use of postoperative therapy for resected SCCHN. Further research is needed in domains where consensus by the expert panel could not be achieved for the appropriateness of specific postoperative therapeutic interventions.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756212PMC
http://dx.doi.org/10.1002/hed.26490DOI Listing

Publication Analysis

Top Keywords

postoperative therapy
24
systematic review
12
therapy resected
12
systematic reviews
12
resected squamous
8
squamous cell
8
cell carcinoma
8
carcinoma head
8
head neck
8
reviews meta-analyses
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!